Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).

Soledad Gallego MelconIlaria ZanettiDaniel OrbachDominique RanchèreJanet ShipleyAngelica ZinChristophe BergeronGian Luca de SalvoJulia ChisholmAndrea FerrariMeriel JenneyHenry C MandevilleTimothy RogersJohannes Hendrikus Maria MerksPeter MudryHeidi GlosliGiuseppe Maria MilanoSima FermanGianni Bisognonull null

Published in: Cancer (2018)

Fusion status and tumor invasiveness appear to have a strong impact on prognosis in patients with aRMS/N1. Fusion status will be used to stratify these patients in the next EpSSG RMS study, and treatment will be intensified in patients with fusion-positive tumors. Cancer 2018. © 2018 American Cancer Society.

Keyphrases

lymph node
papillary thyroid
end stage renal disease
emergency department
chronic kidney disease
intensive care unit
ejection fraction
newly diagnosed
squamous cell
radiation therapy
young adults
rectal cancer